Heart Disease in Women: A New Era of Understanding, Recognition, Prevention, Diagnosis and Treatment 2018

Heart Disease in Women

Heart Disease in Women: A New Era of Understanding, Recognition, Prevention, Diagnosis and Treatment 2018

Leighton Auditorium, Siebens Education Building, Rochester, MN

10/4/2018 - 10/5/2018

Overview

COURSE DESCRIPTION
This educational activity will provide an in-depth assessment of the current status of cardiovascular disease in women, with a focus on risk categories, diagnostic testing modalities and treatment options. The course will offer new paradigms in understanding the mechanisms of sex differences in cardiovascular disease, and provide participants with tools to translate new knowledge into sex- and gender- specific patient care. Focus areas include novel approaches to prevention of cardiovascular disease, and diagnosis and treatment of ischemic heart disease syndromes in women, such as non-obstructive coronary disease, microvascular disease, spontaneous coronary artery dissection, and stress-induced cardiomyopathy.

COURSE HIGHLIGHTS

  • Updates on prevention and treatment of gender specific heart disease

  • Expert faculty presentations focused on advancing cardiovascular health in women

  • Interaction with faculty with question and answer sessions

  • Discussion on diseases women are at risk for:  heart failure, valve disease and arrhythmias

  • Awareness of  new advances for practicing evidence-based medicine

TARGET AUDIENCE
This course is appropriate for, but not limited to, cardiac and vascular specialists, general internists, family practitioners, exercise and nutrition specialists, women’s health care specialists, nurses  and nurse practitioners, hospital administrators and policy makers, and anyone interested in learning about women’s cardiovascular wellness and disease.

OBJECTIVES
Upon completion of this symposium, participants should

  • Recognize the prevalence of heart disease in women
  • Describe differences in epidemiology of cardiovascular disease in women compared to men
  • Identify cardiovascular risk categories and how to assess cardiovascular risk in women
  • Identify sex differences in cardiovascular physiology, pathophysiology and related impact on ischemic heart disease presentations in women
  • Describe diagnostic and treatment options for women with heart failure
  • Recognize and treatment of acquired heart disease in women
  • Identify and manage heart disease in pregnancy

Program

Thursday, October 4, 2018
7:45 a.m.
Registration and Continental Breakfast | Leighton Auditorium Foyer
8:15 a.m.
Welcome and Introductions
Ischemic Heart Disease I
Moderator(s): Rekha Mankad, MD
8:30 a.m.
The Change in the Landscape of Heart Disease in Women?
Nanette Wenger
9:00 a.m.
Diagnosing IHD in women: Functional testing
Sharon Mulvagh, MD
9:20 a.m.
Diagnosing Ischemic Heart Disease in Women: Anatomic Evaluations
Eric Williamson, MD
9:40 a.m.
Unique Considerations in CAD presentation and Treatment in Women
Patricia Best, MD
10:00 a.m.
Questions and Answers
Nanette Wenger, Sharon Mulvagh, MD, Eric Williamson, MD, Patricia Best, MD
10:15 a.m.
Refreshment Break
Ischemic Heart Disease II
Moderator(s): Sharonne N. Hayes, MD
10:35 a.m.
Update in Managing Spontaneous Coronary Artery Dissection (SCAD)
Marysia Tweet, MD
10:55 a.m.
Perspectives in SCAD Diagnosis and Management from the Interventionalist
Rajiv Gulati, MD, PhD
11:15 a.m.
Fibromuscular dysplasia (FMD) and Non-inflammatory Arteriopathies
Ana Casanegra, MD
11:35 a.m.
Regenerative Medicine for Women with Heart Disease: Current and Future State
Atta Behfar, MD, PhD
12:00 p.m.
Questions and Answers
Marysia Tweet, MD, Rajiv Gulati, MD, PhD, Ana Casanegra, MD, Atta Behfar, MD, PhD
12:15 p.m.
Lunch
Addressing Biases and Barriers to Optimal Heart Health in Women
Moderator(s): Rekha Mankad, MD
1:30 p.m.
Blind Spots and Biases: Let’s Start “Seeing” Them
Sharonne N. Hayes, MD
2:00 p.m.
Health for Everyone: Equity for All Women with CVD
La Princess Brewer, MD
2:20 p.m.
Women Don’t Get Cardiac Rehabilitation: Breaking Down Barriers
Amanda Bonikowske, PhD
2:40 p.m.
Questions and Answers
Sharonne N. Hayes, MD, La Princess Brewer, MD, Amanda Bonikowske, PhD
3:00 p.m.
Refreshment Break
Preventive Cardiology
Moderator(s): Sharonne N. Hayes, MD
3:20 p.m.
Call to Action! The Scope and Burden of Women’s CVD Risk
Martha Gulati
3:50 p.m.
“I Can’t (Won’t) Take Statins” An Approach to Statin Intolerance in Women
Stephen Kopecky, MD
4:10 p.m.
Pregnancy and Future Cardiovascular Risk
Andrea Kattah, MD
4:30 p.m.
Culturally and Medically Appropriate CVD Care for Transgender Women
Birgit Kantor, MD
4:50 p.m.
Questions and Answers
Martha Gulati, Stephen Kopecky, MD, Andrea Kattah, MD, Birgit Kantor, MD
5:05 p.m.
Adjourn
Friday, October 5, 2018
7:30 a.m.
Continental Breakfast | Leighton Auditorium Foyer
7:55 a.m.
Welcome
Selected Topics in Women’s Heart Health I
Moderator(s): Sharonne N. Hayes, MD
8:00 a.m.
Principles, Policies and Evidence to Advance CVD Health in Women
Rita Redberg, MD
8:30 a.m.
Cardio-Oncology for Women
Grace Lin, MD
8:50 a.m.
Cardio-Rheumatology: Role of Inflammatory conditions and Heart Disease
Rekha Mankad, MD
9:10 a.m.
Peripheral Arterial Disease in the Women: the Unrecognized Risk
Robert McBane, MD
9:30 a.m.
Questions and Answers
Nanette Wenger, Grace Lin, MD, Rekha Mankad, MD, Robert McBane, MD, Rita Redberg, MD
9:40 a.m.
Refreshment Break
Heart Failure Mini Symposium
Moderator(s): Rekha Mankad, MD
10:00 a.m.
Sex and Gender Considerations in Heart Failure
Eileen Hsich, MD
10:25 a.m.
Heart Failure with Preserved Ejection Fraction (HFpEF) in Women
Margaret Redfield, MD
10:45 a.m.
Stress Cardiomyopathy
Patricia Best, MD
11:05 a.m.
Peripartum Cardiomyopathy
Lori Blauwet, MD
11:25 a.m.
Advanced Heart Failure Therapies in Women
Alfredo Clavell, MD
11:45 a.m.
Participants will pick-up lunch - Lunch panel with patients. Patients will share experiences in dealing with HD
12:00 p.m.
Lunch - Patient Perspective - Panel discussion with patients
Selective Topics in Women’s Heart Health II
Moderator(s): Sharonne N. Hayes, MD
2:00 p.m.
Call to Action! Better Sex and Gender Research in CVD
Virginia Miller, MBA, PhD
2:30 p.m.
Percutaneous Options for Valvular Heart Disease in Women
Charanjit Rihal, MD
2:50 p.m.
The Approach to the Pregnant Patient with Heart Disease
Carole Warnes, MD
3:10 p.m.
Unique EP consideration in Women
Peter Noseworthy, MD
3:30 p.m.
Questions and Answers
Virginia Miller, MBA, PhD, Carole Warnes, MD, Peter Noseworthy, MD, Charanjit Rihal, MD
3:45 p.m.
Closing Remarks: Adjourn

Faculty

COURSE DIRECTORS

Rekha Mankad, M.D.
Sharonne N. Hayes, M.D.

FACULTY

Atta Behfar, MD, PhD
Patricia J M Best, MD
Lori A. Blauwet, MD
Amanda R. Bonikowske, PhD
LaPrincess C. Brewer, MD, MPH
Ana I. Casanegra, MD
Alfredo L. Clavell, MD
Rajiv Gulati, MD, PhD
Birgit Kantor, MD
Andrea G. Kattah, MD
Stephen L. Kopecky, MD
Grace Lin, MD
Robert D. McBane, MD
Virginia M. Miller, PhD
Sharon L. Mulvagh, MD
Peter A. Noseworthy, MD
Margaret M. Redfield, MD
Marysia S Tweet, MD
Carole A. Warnes, MD
Eric E. Williamson, MD

GUEST FACULTY

Eileen Hsich, MD
Nanette Wenger, MD
Martha Gulati, MD
Rita Redberg, MD

FACULTY DISCLOSURE
As a provider accredited by ACCME, Mayo Clinic College of Medicine (Mayo School of Continuous Prefessional Development) must ensure balance, independence, objectivity, and scientific rigor in its educational activities. Course directors, planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.

NATIONAL PHYSICIAN PAYMENT TRANSPARENCY PROGRAM
Mayo Clinic College of Medicine complies with the requirements of the National Physician Payment Transparency Program OPEN PAYMENTS (Physician Payments Sunshine Act).

 

 

Lodging

LODGING ACCOMMODATIONS

Guest rooms have been reserved for attendees and their guests with special course
rates at each of the following downtown Rochester hotels. In order to receive the
special rate, reservations must be made before the room block is filled or before the
expiration date of Thursday, September 10, 2018 whichever comes first. Reservations
will be taken following this date based on space and rate availability. Please identify
yourself as a participant of the course when making your reservation.

Kahler Grand Hotel                                             Double Tree Hotel
20 Second Avenue SW                                      150 South Broadway
800-533-1655                                                      507-281-8000
Executive King:  $149                                         Run of House:  $229
Online Reservations                                            Online Reservations

You may wish to visit the Rochester Convention and Visitors Bureau website www.rochestercvb.org for
additional accommodation options and area information.

Lodging arrangements are the sole responsibility of the individual registrant.

Mayo Clinic Department of Cardiovascular Medicine is not responsible for expenses
incurred by an individual who is not confirmed and for whom space is not available
at the meeting. Costs incurred by the registrant such as airline or hotel fees or
penalties are the responsibility of the registrant.

PARKING
Parking is available in hotel, city, and Mayo Clinic patient/visitor ramps. The cost for
parking is not included in the registration fee.                      

LOCATION
The Heart Disease in Women course will be held October 4-5, 2018.  The course will be held in Leighton Auditorium on the Second Floor of the Siebens Medical Education Building, Mayo Clinic, 100 Second Avenue Southwest, Rochester, Minnesota. Meeting facilities are easily accessible by skyway and pedestrian subway, which connect Mayo Clinic to shops, restaurants, and hotels.

TRAVEL
Rochester, Minnesota is a friendly city that greets thousands of visitors from around the world each year. The city is serviced by a modern international airport with multiple flights daily via American Airlines, Delta Airlines, or United Airlines. Access to and from the airport is provided by taxi, shuttle service, and rental car. The airport is located approximately 10 miles from the Mayo Clinic campus.

Note to Travelers: Several cities in the United States are named Rochester. When you make airline reservations and check your baggage, be sure that your destination is Rochester, Minnesota (RST) and that your baggage has been properly tagged.  Flying through the Minneapolis/St. Paul International Airport (MSP) is another option. (www.mspairport.com). Travel time is approximately 75 minutes.

There are shuttle services to the Rochester area to your hotel from Minneapolis/St. Paul airport.

Go Rochester Direct
800-280-9270 or visit www.gorochesterdirect.com

Rochester Shuttle Service
888-998-9098 or visit www.rochestershuttleservice.com

Travel arrangements are the sole responsibility of the individual registrant.

Commercial Support

At the time of posting, a complete listing of commercial supports (financial or in-kind) was not available. Appropriate acknowledgement will be given to all supporters at the time of the meeting.

EXHIBIT OPPORTUNITIES
This course offers the opportunity for commercial companies to interact with health care providers and highlight their products and services. If you are interested in exhibit space during this course, please contact Char Tri. Exhibits will be available for viewing at all scheduled breaks.


Back to top